Trident Lifeline Ltd

₹ 143 -3.87%

29 Mar - close price

About

Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing of pharmaceutical products in domestic and international markets. The company is also engaged in distribution of pharmaceutical products through third-party distribution network.^[1]

Key Points

Business categories^[1]
1. Ethical marketing of pharmaceutical formulation & products in International Markets through a third-party distribution network and sales force under its own brand
2. Getting approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines in Domestic and International Market.

Website BSE

Market Cap ₹ 164 Cr.
Current Price ₹ 143
High / Low ₹ 180 / 103
Stock P/E 72.4
Book Value ₹ 6.00
Dividend Yield 0.00 %
ROCE 56.4 %
ROE 105 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.

Cons

Stock is trading at 23.8 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
Company might be capitalizing the interest cost
Debtor days have increased from 68.2 to 83.3 days.
Working capital days have increased from 22.2 days to 66.7 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2021	Sep 2022	Dec 2022
	4.46	7.85	9.41
	5.04	6.26	7.42
Operating Profit	-0.58	1.59	1.99
OPM %	-13.00%	20.25%	21.15%
	0.03	0.12	0.39
Interest	0.03	0.17	0.13
Depreciation	0.05	0.06	0.13
Profit before tax	-0.63	1.48	2.12
Tax %	0.00%	0.00%	4.72%
Net Profit	-0.63	1.48	2.02
EPS in Rs	-0.97	1.85	1.76
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2020	Mar 2021	Mar 2022
	4.93	9.62	21.77
	5.20	8.37	18.98
Operating Profit	-0.27	1.25	2.79
OPM %	-5.48%	12.99%	12.82%
	0.07	0.16	0.60
Interest	0.76	0.41	0.13
Depreciation	0.12	0.14	0.20
Profit before tax	-1.08	0.86	3.06
Tax %	25.93%	25.58%	25.82%
Net Profit	-0.80	0.63	2.27
EPS in Rs	-2.58	1.26	2.84
Dividend Payout %	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	126%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	260%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	105%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2020	Mar 2021	Mar 2022
	3.10	5.00	8.00
Reserves	-6.10	-5.47	-3.20
	6.46	4.53	2.46
	2.93	7.39	6.60
Total Liabilities	6.39	11.45	13.86
	0.77	1.18	1.43
CWIP	0.00	0.00	0.00
Investments	0.00	0.00	0.05
	5.62	10.27	12.38
Total Assets	6.39	11.45	13.86

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2020	Mar 2021	Mar 2022
	-0.59	1.48	-0.25
	-0.08	-0.56	-0.51
	0.76	-0.96	0.79
Net Cash Flow	0.08	-0.03	0.04

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2020	Mar 2021	Mar 2022
Debtor Days	96.99	24.28	83.33
Inventory Days	103.66	349.10	95.16
Days Payable	201.80	266.30	145.95
Cash Conversion Cycle	-1.15	107.09	32.54
Working Capital Days	-11.85	11.76	66.73
ROCE %		33.78%	56.36%

Shareholding Pattern

Numbers in percentages

10 recently

	Dec 2022
	69.85
	4.20
	25.95

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

No data available.

Concalls

Jan 2023

Transcript

Notes
PPT